Fluorine Atoms on C6H5-Corrole Affect the Interaction with Mpro and PLpro Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
暂无分享,去创建一个
Carolina Q. Sacramento | H. Castro-Faria-Neto | C. Sacramento | T. Souza | J. Temerozo | A. Echevarria | O. Chaves | N. Fintelman-Rodrigues | C. E. Rodrigues-Santos | J. R. Temerozo | T. M. Souza
[1] Carolina Q. Sacramento,et al. Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones , 2022, Viruses.
[2] H. Castro-Faria-Neto,et al. Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way , 2022, Journal of molecular cell biology.
[3] S. Olsen,et al. Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development , 2022, Frontiers in Chemistry.
[4] Carolina Q. Sacramento,et al. Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo , 2021, bioRxiv.
[5] B. Iglesias,et al. Unveiling the photophysical, biomolecule binding and photo-oxidative capacity of novel Ru(II)-polypyridyl corroles: A multipronged approach , 2021 .
[6] Sangdun Choi,et al. Exploring the Binding Mechanism of PF-07321332 SARS-CoV-2 Protease Inhibitor through Molecular Dynamics and Binding Free Energy Simulations , 2021, International journal of molecular sciences.
[7] Carolina Q. Sacramento,et al. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites , 2021, International journal of molecular sciences.
[8] M. Lebedev,et al. Possible therapeutic targets and promising drugs based on unsymmetrical hetaryl-substituted porphyrins to combat SARS-CoV-2 , 2021, Journal of Pharmaceutical Analysis.
[9] O. Koifman,et al. Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins , 2021, Chemistry of Heterocyclic Compounds.
[10] Yann-Mickael Dalmat. Sars-CoV-2 : histoire de mutants , 2021, Option/Bio.
[11] S. Irfan,et al. Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19 , 2021, Saudi Journal of Biological Sciences.
[12] M. Lonardoni,et al. A systematic review of photodynamic therapy as an antiviral treatment: Potential guidance for dealing with SARS-CoV-2 , 2021, Photodiagnosis and Photodynamic Therapy.
[13] A. Kasry,et al. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant , 2021, Medicine in Drug Discovery.
[14] T. Tencomnao,et al. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach , 2021, Journal of Traditional and Complementary Medicine.
[15] R. Menna-Barreto,et al. Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] M. Baig,et al. Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19 , 2020, Current Research in Structural Biology.
[17] L. Perera,et al. Potential SARS-CoV-2 main protease inhibitors , 2020, Drug Discovery Today.
[18] D. Qu,et al. Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2 , 2020, Science Bulletin.
[19] Jaeyong Lee,et al. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site , 2020, Nature Communications.
[20] Tao Wang,et al. Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection , 2020, Biomedicine & Pharmacotherapy.
[21] B. Iglesias,et al. Fluorescent pyrene moiety in fluorinated C6F5-corroles increases the interaction with HSA and CT-DNA , 2020 .
[22] S. Gayen,et al. Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors , 2020, Bioorganic & Medicinal Chemistry.
[23] I. Tuñón,et al. Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods , 2020, ACS catalysis.
[24] Robert C. Harris,et al. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: Implication for designing broad-spectrum antiviral inhibitors , 2020, The Journal of chemical physics.
[25] Kanikar Muangchoo,et al. A Computational Study to Identify Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) from Eucalyptus Active Compounds , 2020, Comput..
[26] Meitian Wang,et al. Crystal structure of SARS-CoV-2 papain-like protease , 2020, Acta Pharmaceutica Sinica B.
[27] Cooper A. Taylor,et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors , 2020, Nature Communications.
[28] Carolina Q. Sacramento,et al. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production , 2020, Antimicrobial Agents and Chemotherapy.
[29] W. D. dos Santos,et al. Natural history of COVID-19 and current knowledge on treatment therapeutic options , 2020, Biomedicine & Pharmacotherapy.
[30] J. J. Rodríguez,et al. Synthesis and photophysics of benzazole based triazoles with amino acid-derived pendant units. Multiparametric optical sensors for BSA and CT-DNA in solution , 2020 .
[31] F. Iacovelli,et al. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors , 2020, Virus Research.
[32] L. Dodd,et al. Remdesivir for the Treatment of Covid-19 — Final Report , 2020, The New England journal of medicine.
[33] A. Joachimiak,et al. Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography , 2020, Nature Communications.
[34] J. Tuszynski,et al. Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design , 2020, International journal of molecular sciences.
[35] Mubarak A. Alamri,et al. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants , 2020, Journal of Pharmaceutical Analysis.
[36] N. Kipshidze,et al. Photodynamic therapy for COVID-19 , 2020, Nature Photonics.
[37] O. Santos-Filho. Identification of Potential Inhibitors of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Main Protease from Non-Natural and Natural Sources: A Molecular Docking Study , 2020 .
[38] Hui-Yao Huang,et al. The photodynamic activity and toxicity evaluation of 5,10,15-tris(ethoxylcarbonyl)corrole phosphorus(V) in vivo and in vitro. , 2019, European journal of medicinal chemistry.
[39] B. Röder,et al. Singlet oxygen luminescence kinetics under PDI relevant conditions of pathogenic dermatophytes and molds. , 2018, Journal of photochemistry and photobiology. B, Biology.
[40] Proton-Coupled Conformational Allostery Modulates the Inhibitor Selectivity for β-Secretase. , 2017, The journal of physical chemistry letters.
[41] R. P. Pereira,et al. Investigation of interaction between human plasmatic albumin and potential fluorinated anti-trypanosomal drugs , 2017 .
[42] C. M. Sant’Anna,et al. Biological interactions of fluorinated chalcones: Stimulation of tyrosinase activity and binding to bovine serum albumin , 2017 .
[43] H. Gray,et al. Fighting Cancer with Corroles. , 2017, Chemical reviews.
[44] A. Mesecar,et al. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds , 2014, Antiviral Research.
[45] A. Bortoluzzi,et al. Synthesis, antileishmanial activity and structure-activity relationship of 1-N-X-phenyl-3-N'-Y-phenyl-benzamidines. , 2013, European journal of medicinal chemistry.
[46] T. Goslinski,et al. Fluorinated porphyrinoids and their biomedical applications , 2011 .
[47] Andrew D Westwell,et al. The role of fluorine in medicinal chemistry , 2007, Journal of enzyme inhibition and medicinal chemistry.
[48] Zhongbin Chen,et al. The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity , 2005, Journal of Virology.
[49] D. Gryko,et al. Photophysical characterization of free-base corroles, promising chromophores for light energy conversion and singlet oxygen generation , 2005 .
[50] D. Modarelli,et al. Photophysical properties of a series of free-base corroles. , 2005, The journal of physical chemistry. A.
[51] L. Eriksson,et al. Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. , 2003, Environmental Health Perspectives.
[52] Rolf Hilgenfeld,et al. Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.
[53] Eliana Zandonade,et al. Proposição, validação e análise dos modelos que correlacionam estrutura química e atividade biológica , 2001 .
[54] U Norinder,et al. Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[55] Anderson Coser Gaudio,et al. BuildQSAR: A New Computer Program for QSAR Analysis , 2000 .
[56] N. Galili,et al. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis. , 2000, Cancer research.
[57] Gary O. Spessard,et al. ACD Labs/LogP dB 3.5 and ChemSketch 3.5 , 1998, J. Chem. Inf. Comput. Sci..
[58] W. A. WATERS,et al. Physical Organic Chemistry: , 1941, Nature.